STOCK TITAN

Transcat SEC Filings

TRNS NASDAQ

Welcome to our dedicated page for Transcat SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Transcat Inc. filings document material events for a calibration services and test-instrument distribution company. Recent Form 8-K reports cover quarterly results furnished under Item 2.02, earnings press releases and presentation exhibits, and Regulation FD disclosures tied to operating updates.

The company’s filings also record governance and equity-compensation matters, including executive appointments, officer transitions, retention equity awards, and transition agreements. Acquisition-related 8-K disclosures describe completed purchases of calibration laboratory businesses, related material agreements, consideration, exhibits, and customary representations, warranties and holdback provisions.

Rhea-AI Summary

Transcat, Inc. reported that Principal Accounting Officer Kristina L. Johnston received a grant of 409 Restricted Stock Units (RSUs), each convertible into one share of common stock. These RSUs were granted under the Transcat, Inc. 2021 Stock Incentive Plan and, except as otherwise provided in the award notice, vest on March 31, 2029.

The filing also shows an existing holding of 358 RSUs, which vest on March 25, 2028, giving her a staged equity-based compensation position over the next several years. All RSUs carry a conversion price of $0.0000 per share, reflecting their nature as stock-based awards rather than open-market purchases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Transcat Inc. Chief Operating Officer Michael W. West reported routine equity compensation activity involving common stock and restricted stock units. West received 1,051 shares of common stock as a grant awarded upon the vesting of performance-based restricted stock units under the company’s 2021 Stock Incentive Plan, based on adjusted EBITDA performance over a three-year period ending in fiscal 2026. To cover tax withholding obligations on this vesting, 465 shares of common stock were withheld at $76.45 per share. Following these transactions, West directly holds 27,551 shares of common stock, which includes 16 shares acquired under the Employee Stock Purchase Plan. He also received a new grant of 1,807 restricted stock units (RSUs) that convert into common stock on a one-for-one basis and, except as otherwise provided in the award notice, vest on March 31, 2029. In addition, he holds several other RSU awards tied to common stock that vest on future dates including April 8, 2027, March 27, 2027, January 6, 2028, and March 25, 2028, as disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Haddad Michael Jacques reported acquisition or exercise transactions in this Form 4 filing.

Transcat Inc.’s Chief Information Officer Michael Jacques Haddad received a grant of 1,382 restricted stock units (RSUs), each convertible into one share of common stock on a one-for-one basis. These RSUs were granted under the Transcat, Inc. 2021 Stock Incentive Plan and, except as otherwise provided in the award notice, vest on March 31, 2029.

The filing also lists existing RSU awards with underlying common shares of 730, 1,017 and 5,190, which vest on March 27, 2027, January 6, 2028 and March 25, 2028, respectively, providing a schedule of future equity-based compensation for the executive.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Transcat Inc Chief Human Resources Officer Theresa A. Conroy reported equity compensation activity rather than open-market trading. She received an award of 759 shares of common stock at $0.00 per share upon vesting of performance-based restricted stock units that were granted under the company’s 2021 Stock Incentive Plan and tied to adjusted EBITDA goals over a three-year period ending in fiscal 2026. To cover related taxes, 335 shares of common stock were withheld at $76.45 per share, a non-market disposition. Conroy also received a new grant of 1,382 restricted stock units that convert into common stock on a one-for-one basis and are scheduled to vest on March 31, 2029. After these transactions, she holds 2,696 shares of common stock directly and maintains multiple blocks of outstanding restricted stock units and a fully exercisable option for 2,000 shares at an exercise price of $63.17 per share expiring on May 25, 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Transcat Inc Sr. VP Finance & CFO Thomas L. Barbato reported equity compensation activity involving performance-based restricted stock units and new awards. He received 1,719 shares of common stock upon vesting of performance-based RSUs granted under the 2021 Stock Incentive Plan, after the company met pre-determined adjusted EBITDA thresholds over a three-year period ending in fiscal 2026. To cover related tax obligations, 760 shares of common stock were withheld rather than sold on the open market. Barbato was also granted 3,925 new RSUs, which convert into common stock on a one-for-one basis and generally vest on March 31, 2029. Following these transactions, he directly holds 5,409 shares of common stock and continues to hold stock options and additional RSU awards with future vesting dates and option expirations in 2027 and 2028.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Transcat Inc. reported that President and CEO Jaime A. Irick received a grant of 15,043 restricted stock units (RSUs). These RSUs were awarded at no cash cost under the Transcat, Inc. 2021 Stock Incentive Plan and convert into common stock on a one-for-one basis.

According to the award terms, the RSUs generally vest on March 31, 2029, subject to the plan and award notice conditions. Following this grant, Irick holds 15,043 RSUs directly, reflecting a compensation-related equity award rather than an open-market share purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Transcat, Inc. files its annual report describing a calibration‑focused services and test equipment distribution business aimed at highly regulated industries such as life sciences, aerospace and energy. The company operates two segments, with Service positioned as the main long‑term growth driver.

Transcat runs 33 calibration service centers across North America and Ireland, added a Costa Rica lab in April 2026, and performs over 1.2 million calibrations annually for about 27,000 customers. Recent acquisitions include Essco in fiscal 2026, its largest deal, plus Martin and Becnel in fiscal 2025, all aimed at geographic expansion and capabilities.

The report highlights an Operational Excellence initiative, proprietary CalTrak® and C3® asset management platforms, and a strategy to cross‑sell between Service and Distribution. Key risks center on macroeconomic conditions, intense competition (including online and direct‑from‑vendor channels), acquisition integration, cybersecurity, supply chain disruptions and a $99.9 million debt balance under a $150 million credit facility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

Transcat, Inc. reported strong top-line growth but weaker earnings for its fiscal fourth quarter and full year ended March 28, 2026. Q4 revenue rose 15.8% to $89.3 million, led by 18.4% growth in service revenue to $61.6 million and 10.5% growth in distribution revenue to $27.8 million. Q4 gross margin improved to 34.1%, and Adjusted EBITDA* increased 16.0% to $14.8 million, but operating income fell 37.6% to $4.3 million and net income declined to $1.9 million, or $0.21 per diluted share.

For fiscal 2026, total revenue grew 19.2% to $331.9 million, with service revenue up 19.7% and distribution revenue up 18.2%. Full‑year gross margin expanded 50 basis points to 32.6% and Adjusted EBITDA* rose 22.7% to $48.7 million, while operating income decreased 25.8% to $13.3 million and net income dropped 63.0% to $5.4 million, or $0.57 per diluted share. Management attributes higher operating expenses to acquisitions, increased amortization, stock-based compensation, executive transition costs and incentives, and continues to guide to high single-digit service organic revenue growth for fiscal 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
current report
-
Rhea-AI Summary

Transcat, Inc. reported a change to executive compensation for its Chief Operating Officer, Michael W. West. Effective as of March 29, 2026, for the fiscal year ending March 27, 2027, Mr. West will receive a base salary of $425,000 per year, a target performance-based cash incentive equal to 40% of base salary, and a target long-term equity incentive equal to 65% of base salary. These elements together define his compensation opportunity for fiscal 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Vanguard Capital Management reports beneficial ownership of 475,732 shares of Transcat Inc Common Stock, equal to 5.09% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over 475,732 shares and sole voting power over 68,571 shares, and that these holdings include securities held for Vanguard funds and managed accounts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership

FAQ

How many Transcat (TRNS) SEC filings are available on StockTitan?

StockTitan tracks 51 SEC filings for Transcat (TRNS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Transcat (TRNS)?

The most recent SEC filing for Transcat (TRNS) was filed on May 28, 2026.